Medical Properties Trust, Inc. (MPT) falls on deep earnings
Medical Properties Trust, Inc. (MPT) beat EPS and revenue, yet shares fell as investors looked past the headline to debt, rent collection, and tenant recovery. This deep-dive examines coverage ratios, refinancing progress, normalized FFO, and the path to more durable cash flow.
Medical Properties Trust, Inc. (MPT) reported a strong second quarter, with EPS of $0.15 versus a $0.00471 estimate and revenue of $0.26 billion versus $0.25 billion expected. Even so, the stock fell 12.45% as investors looked past the beat and focused on debt costs, rent collection, and uneven tenant recovery. For investors, the quarter improves the earnings picture, but the real test remains whether MPT can keep normalizing cash rent and reduce balance-sheet risk.
Medical Properties Trust, Inc. (MPT) falls after earnings
Medical Properties Trust, Inc. (MPT) falls 12.45% to $4.115 in regular trading despite reporting $0.15 EPS against a $0.00471 estimate and $0.26B in revenue against $0.25B consensus. Trading volume reached 23.62 million shares versus a 5.65 million average, turning a clear earnings beat into a sharp test of investor confidence. The reaction shows that MPT earnings are being judged on debt, rent collection, and tenant recovery as much as quarterly profit.
Key Takeaways
MPT reported $0.15 EPS versus a $0.00471 estimate. Revenue reached $0.26B, beating the $0.25B consensus.
Post-acute operators led the portfolio. EBITDARM increased by more than $70 million year over year, driven by a 24% increase at Median and a 13% increase at Ernest Health.
General acute coverage remained stable at 2.8x, while post-acute coverage reached 2.4x. Behavioral health coverage fell slightly to 1.4x.
Management expects annualized cash rent to exceed $1B by the end of 2026. HSA is paying 75% of contractual rent and is scheduled to reach 100% in mid-September. NOR is paying 50% and is scheduled to reach 100% in mid-December.
A refinancing transaction addresses $2.4B of debt maturities through 2032. MPT expects no debt maturities in 2026 or 2027, with about $600M due in June 2028.
Analyst sentiment remains balanced. The consensus is Hold, with 11 Buy ratings, 13 Holds, and four Sells. RBC Capital maintained Sector Perform while cutting its price target from $5.00 to $4.50 on June 18.
Medical Properties Trust Earnings and Financial Performance
MPT's second-quarter results delivered a headline beat on both earnings and revenue. The company reported $0.15 EPS, well above the $0.00471 estimate. Revenue came in at $0.26B, ahead of the $0.25B consensus. For a healthcare facilities REIT still repairing its balance sheet, that combination provides a solid quarterly starting point.
Revenue also improved from $0.25B in the first quarter of 2026 and $0.24B in the third quarter of 2025. The second-quarter figure matched the strongest revenue result in the five-quarter financial history provided, which was $0.27B in the fourth quarter of 2025. Net income was $0.02B, compared with $0.03B in the first quarter.
The earnings history shows a sharp improvement in reported EPS from the losses recorded in 2025. MPT posted EPS of negative $0.16 in the quarter ended June 30, 2025, and negative $0.13 in the quarter ended September 30, 2025. EPS then turned positive at $0.0283 in December, $0.0542 in March, and $0.15 in the latest quarter.
The call also presented normalized FFO of $0.15 per share, compared with $0.14 per share in the prior quarter. That distinction matters for REIT analysis because normalized FFO better reflects recurring property earnings than GAAP net income alone. Still, investors focused less on the clean quarterly beat and more on whether cash rent will continue to recover.
The operating portfolio was uneven. General acute facilities produced aggregate EBITDARM coverage of 2.8x. Post-acute assets delivered 2.4x coverage and the strongest growth in the portfolio. Behavioral health coverage slipped to 1.4x, reflecting pressure in the US and UK.
Several individual operators shaped the quarter. Median reported a 24% increase in EBITDARM, while Ernest Health increased EBITDARM by 13%. Ernest also plans to add seven hospitals through its Reunion Rehabilitation Hospitals acquisition. In contrast, UK behavioral operations faced funding pressure from the National Health Service, while HSA experienced lower collections after a MEDITECH electronic medical record conversion.
MPT also recorded about $17 million of impairments in working capital loans, primarily tied to two Steward replacement tenants in the Midwest. General and administrative expense increased year over year because of higher stock compensation expense and depreciation tied to the corporate headquarters building placed into service in the first quarter.
The quarter therefore combines improving earnings with continuing tenant execution risk. Post-acute assets are carrying the growth narrative, but behavioral health and selected US operators still require operational repair.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MPT shares traded at $4.115 after six hours of regular-session activity on Aug. 10, 2026, down 12.45%. Volume reached 23,619,840 shares, compared with an average of 5,651,472. The heavy selling stands in direct contrast to the EPS and revenue beats.
That contrast is the central market message. The quarter produced better reported earnings, but the refinancing carries a 9.25% coupon, and the company still relies on tenant rent normalization and asset sales to strengthen liquidity. In plain English, investors are pricing the cost of the repair work rather than applauding the quarter's accounting win.
The analyst consensus remains Hold. Eleven analysts carry Buy ratings, 13 rate the stock Hold, and four rate it Sell. RBC Capital's latest clearly documented action came on June 18, when it maintained Sector Perform and reduced its price target from $5.00 to $4.50.
MarketBeat's broader rating summary lists three upgrades and one downgrade over the prior 90 days. However, the latest formal action in the analyst-rating record remains RBC's neutral call and lower target. The $4.50 target sits above the current $4.115 share price, but the Hold consensus signals limited conviction in a rapid rerating.
The price action also reflects a familiar REIT tension. A stock can beat quarterly estimates while investors still question the durability of cash flows, the cost of debt, and the quality of tenant credits. MPT's 12.45% decline shows that those concerns currently outweigh the income statement beat.
Medical Properties Trust Management Commentary
CEO Edward K. Aldag Jr. framed the quarter around balance-sheet repair and portfolio positioning. The most important strategic move was a two-step refinancing that addresses about $2.7B of 2026 and 2027 maturities, plus approximately $1.2B of longer-dated unsecured notes. The transaction includes $2.4B of secured notes and an exchange of longer-dated debt at a discount.
“With the strong trends we continue to see across our diverse portfolio of operators, the enduring value of our assets, and a plan to clear the runway of debt maturities until late 2028, we are well positioned to achieve our goal of over $1 billion annualized cash rent by the end of the year.” - Edward K. Aldag Jr., CEO, Earnings Call
Aldag also supplied the macro narrative. He described robust global demand for rehabilitation services and highlighted Switzerland as a growth market after MPT's joint venture, Infracore, went public on the SIX Exchange. At the same time, he acknowledged funding pressure from the NHS in the UK and continued weakness in behavioral health.
“General Acute performance was stable. Behavioral health remains a source of pressure on the overall portfolio.” - Edward K. Aldag Jr., CEO, Earnings Call
The CEO's message is straightforward: MPT wants investors to value the portfolio through its long-term rent potential, not only through current tenant stress. The company consolidated its ScionHealth general acute hospitals and LifePoint leases into one LifePoint master lease. Management said the change creates a single lease relationship with a mature operator and an enhanced credit profile.
CFO R. Steven Hamner supplied the financial detail behind that strategy. MPT's secured notes carry a 9.25% coupon and a 5.5-year term, with prepayment permitted after two years. The refinancing removes 2026 and 2027 maturities, but the coupon places a meaningful cost on the balance-sheet reset.
“Today, we reported normalized FFO of $0.15 per share for the second quarter of 2026, which was in line with our expectations as last quarter's results were $0.14 per share.” - R. Steven Hamner, CFO, Earnings Call
Hamner said MPT expects $1.1B of liquidity based on recent and near-term asset sales. He also said the company's bond maintenance covenant, which requires 150% of unencumbered assets over unsecured debt, could improve to almost 300%, depending on liquidity deployment.
“MPT will then have no debt maturing in 2026 or 2027. In fact, our sole maturity over the next 3 years will be a modest balance of about $600 million of notes due in June 2028.” - R. Steven Hamner, CFO, Earnings Call
The CFO also pointed to asset values above original investments. One transaction is expected to generate about $172M in after-debt cash proceeds, representing a 60% increase over the original investment and an approximate 34% IRR. That evidence supports management's argument that asset sales can help reduce debt without simply liquidating at distressed prices.
Tenant guidance remains just as important. HSA's MEDITECH conversion caused temporary billing and collection problems in May and June. HSA moved revenue-cycle management back in-house, and Florida supplemental funding began arriving in August. NOR started paying 50% of contractual rent in June, while HSA is scheduled to reach full contractual rent in mid-September.
Bottom Line
MPT delivered a clear quarterly beat, stronger post-acute performance, and a materially cleaner debt maturity schedule. Yet the 12.45% share-price fall shows that investors still demand proof that rent normalization and asset sales can overcome tenant risk and the 9.25% refinancing cost. The investment case now rests on execution toward more than $1B of annualized cash rent and sustained debt reduction.
+Why did Medical Properties Trust (MPT) stock fall after beating earnings?
MPT fell 12.45% to $4.115 because investors focused on debt, rent collection, and tenant recovery rather than the headline earnings beat. The company reported $0.15 EPS versus a $0.00471 estimate and $0.26 billion in revenue versus $0.25 billion expected, but the market still viewed the balance-sheet repair as the bigger issue.
+Did Medical Properties Trust (MPT) beat EPS and revenue in the latest quarter?
Yes. MPT reported EPS of $0.15, well above the $0.00471 estimate, and revenue of $0.26 billion versus the $0.25 billion consensus. Normalized FFO also came in at $0.15 per share, up from $0.14 in the prior quarter.
+What were the key operating trends in Medical Properties Trust's portfolio?
General acute facilities posted 2.8x coverage and post-acute assets reached 2.4x coverage, while behavioral health coverage slipped to 1.4x. EBITDARM rose more than $70 million year over year, led by a 24% increase at Median and a 13% increase at Ernest Health.
+What does Medical Properties Trust's debt refinancing mean for investors?
The refinancing addresses $2.4 billion of debt maturities through 2032, and MPT expects no debt maturities in 2026 or 2027. However, the new financing carries a 9.25% coupon, so investors are still watching whether rent normalization and asset sales can improve liquidity fast enough.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on MPT?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
